InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,813.12
(
0.03%
)
Post# of 63
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

xr_biotech_consult

Send PM Follow Ignore
Followers 16
Posts 1145
Boards Moderated 0
Alias Born 03/12/2010

xr_biotech_consult

Re: None

Wednesday, 07/08/2015 12:24:20 PM

Wednesday, July 08, 2015 12:24:20 PM

Post# of 63
IMMUNOVACCINE AND PHARMATHENE SIGN EXCLUSIVE WORLDWIDE LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE AN ANTHRAX VACCINE FORMULATED IN DEPOVAXTM
http://www.twst.com/update/116153-pharmathene-inc-immunovaccine-and-pharmathene-sign-exclusive-worldwide-license-agreement-to-develop-and-commercialize-an-anthrax-vaccine-formulated-in-depovaxtm
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IMV News
More IMV News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!